ArticleResearch square2026
Serum MMP-3/TIMP-1 ratio is a potential diagnostic marker for HIV-associated neurocognitive disorders.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Persistent central nervous system (CNS) inflammation and chronic immune activation contribute to HIV-1-associated neurocognitive disorders (HAND). Imbalances in the matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have been implicated in HAND pathogenesis. We hypothesized that MMP levels would be higher in the HAND group than in the other groups. This study assessed MMPs and TIMPs in the cerebrospinal fluid (CSF) and serum of people with HIV (PWH, n=68) and people without HIV (PWoH, n=19) categorized by neurocognitive performance using the Global Deficit Score (GDS) and HAND classification. Biomarker levels were compared using linear regression adjusted for plasma HIV RNA suppression and nadir CD4. The Benjamini-Hochberg method was used for multiple testing adjustment, and Spearman method (ρ) for correlation. Serum MMP-3/TIMP-1 ratio levels were elevated in the group with GDS >0.5 versus GDS <0.5 [0.048 (0.029; 0.068) versus 0.028 (0.018; 0.049), Cohen's d 0.811 (0.274, 1.348), p BH-adjusted 0.036]. Working memory deficit was weakly correlated with MMP-2, MMP-9, TIMP-1, MMP-9/TIMP-1, and MMP-2/TIMP-2 in CSF (ρ 0.277-0.383), there was no correlation of these biomarkers in serum. The area under the receiver operating characteristic curve of MMP-3/TIMP-1 ratio for HAND diagnosis was 0.67, sensitivity was 64% (46%-79%), and specificity was 67% (45%-84%). Conclusion: Serum MMP-3/TIMP-1 ratio is a promising diagnostic biomarker of HAND, potentially eliminating the need for lumbar puncture and CSF collection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.